TG THERAPEUTICS, INC. (13)
Browse by Contract Category
Contracts
-
Description of Securities of TG Therapeutics, Inc
(Filed With SEC on March 1, 2021)
-
Underwriting Agreement, dated December 14, 2020, by and among TG Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Cantor...
(Filed With SEC on December 16, 2020)
-
Amendment to TG Therapeutics, Inc. Amended and Restated 2012 Incentive Plan
(Filed With SEC on June 24, 2020)
-
At Market Issuance Sales Agreement, among the Company and Jefferies LLC, Cantor Fitzgerald & Co. and B. Riley FBR, Inc., dated March 20, 2020
(Filed With SEC on March 20, 2020)
-
Underwriting Agreement, dated May 14, 2020, by and among TG Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, Evercore Group L.L.C. and Cantor Fitzgerald & Co., as...
(Filed With SEC on May 18, 2020)
-
Description of Securities of TG Therapeutics, Inc
(Filed With SEC on March 2, 2020)
-
Amended and Restated Collaboration Agreement by and between TG Therapeutics, Inc. and Checkpoint Therapeutics, Inc., dated June 19, 2019
(Filed With SEC on August 9, 2019)
-
Master Services Agreement between Samsung Biologics Co., Ltd. and TG Therapeutics, Inc., effective February 21, 2018
(Filed With SEC on August 9, 2019)
-
Underwriting Agreement, dated March 1, 2019, by and between TG Therapeutics, Inc. and Cantor Fitzgerald & Co
(Filed With SEC on March 5, 2019)
-
Warrant Agreement, dated February 28, 2019, by and between TG Therapeutics, Inc. and Hercules Capital, Inc
(Filed With SEC on March 5, 2019)
-
Warrant Agreement, dated February 28, 2019, by and between TG Therapeutics, Inc. and Hercules Technology III, L.P
(Filed With SEC on March 5, 2019)
-
Loan and Security Agreement, dated February 28, 2019, by and among TG Therapeutics, Inc., TG Biologics, Inc. and Hercules Capital, Inc
(Filed With SEC on March 5, 2019)
-
Master Services Agreement, effective February 21, 2018
(Filed With SEC on March 1, 2019)